117 related articles for article (PubMed ID: 31586548)
1. DIAPH3 promotes the tumorigenesis of lung adenocarcinoma.
Xiang G; Weiwei H; Erji G; Haitao M
Exp Cell Res; 2019 Dec; 385(1):111662. PubMed ID: 31586548
[TBL] [Abstract][Full Text] [Related]
2. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
3. NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.
Zhang H; Wang A; Tan Y; Wang S; Ma Q; Chen X; He Z
J Cell Mol Med; 2019 Oct; 23(10):6965-6977. PubMed ID: 31448526
[TBL] [Abstract][Full Text] [Related]
4. LncRNA TP73-AS1 promoted the progression of lung adenocarcinoma via PI3K/AKT pathway.
Liu C; Ren L; Deng J; Wang S
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30541897
[TBL] [Abstract][Full Text] [Related]
5. ZSWIM1 Promotes the Proliferation and Metastasis of Lung Adenocarcinoma Cells through the STK38/MEKK2/ERK1/2 Axis.
Gao X; Lian Q; Guan B; Liu QY; Meng M; Chen Y; Jin J; Li H; Liu X; Sun Z; Liu L; He QY; Zhang G
J Proteome Res; 2023 Apr; 22(4):1080-1091. PubMed ID: 36511424
[TBL] [Abstract][Full Text] [Related]
6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
He D; Wu Z; He J; Wang Y; Li Z; Gao S
Gene; 2019 May; 696():47-53. PubMed ID: 30771479
[TBL] [Abstract][Full Text] [Related]
8. Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.
Zhang Y; Wu X; Kai Y; Lee CH; Cheng F; Li Y; Zhuang Y; Ghaemmaghami J; Chuang KH; Liu Z; Meng Y; Keswani M; Gough NR; Wu X; Zhu W; Tzatsos A; Peng W; Seto E; Sotomayor EM; Zheng X
JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852841
[TBL] [Abstract][Full Text] [Related]
9. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
10. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
[TBL] [Abstract][Full Text] [Related]
11. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
12. The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma.
Qiu M; Xia W; Chen R; Wang S; Xu Y; Ma Z; Xu W; Zhang E; Wang J; Fang T; Hu J; Dong G; Yin R; Wang J; Xu L
Cancer Res; 2018 Jun; 78(11):2839-2851. PubMed ID: 29588350
[TBL] [Abstract][Full Text] [Related]
13. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of FOXP1 promotes the development of lung adenocarcinoma.
Sheng H; Li X; Xu Y
Cancer Biol Ther; 2019; 20(4):537-545. PubMed ID: 30409062
[TBL] [Abstract][Full Text] [Related]
15. PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis.
Kim MJ; Cervantes C; Jung YS; Zhang X; Zhang J; Lee SH; Jun S; Litovchick L; Wang W; Chen J; Fang B; Park JI
Mol Cell; 2021 Apr; 81(8):1698-1714.e6. PubMed ID: 33626321
[TBL] [Abstract][Full Text] [Related]
16. IκB Kinase α Is Required for Development and Progression of
Vreka M; Lilis I; Papageorgopoulou M; Giotopoulou GA; Lianou M; Giopanou I; Kanellakis NI; Spella M; Agalioti T; Armenis V; Goldmann T; Marwitz S; Yull FE; Blackwell TS; Pasparakis M; Marazioti A; Stathopoulos GT
Cancer Res; 2018 Jun; 78(11):2939-2951. PubMed ID: 29588349
[TBL] [Abstract][Full Text] [Related]
17. KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.
Wu GJ; Pen J; Huang Y; An S; Liu Y; Yang Y; Hao Q; Guo XX; Xu TR
Mol Carcinog; 2018 Oct; 57(10):1396-1407. PubMed ID: 29917268
[TBL] [Abstract][Full Text] [Related]
18. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
19. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
